SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054494
Filing Date
2021-11-04
Accepted
2021-11-04 16:17:08
Documents
49
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20210930.htm   iXBRL 10-Q 2333283
2 EX-31.1 kura-ex311_10.htm EX-31.1 17447
3 EX-31.2 kura-ex312_6.htm EX-31.2 17278
4 EX-32.1 kura-ex321_7.htm EX-32.1 9557
  Complete submission text file 0001564590-21-054494.txt   6685523

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kura-20210930.xsd EX-101.SCH 31939
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20210930_cal.xml EX-101.CAL 44923
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20210930_def.xml EX-101.DEF 82657
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20210930_lab.xml EX-101.LAB 265715
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20210930_pre.xml EX-101.PRE 185927
10 EXTRACTED XBRL INSTANCE DOCUMENT kura-10q_20210930_htm.xml XML 1237100
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 211380211
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences